GR3018303T3 - Transdermal estradiol delivery system. - Google Patents
Transdermal estradiol delivery system.Info
- Publication number
- GR3018303T3 GR3018303T3 GR950403422T GR950403422T GR3018303T3 GR 3018303 T3 GR3018303 T3 GR 3018303T3 GR 950403422 T GR950403422 T GR 950403422T GR 950403422 T GR950403422 T GR 950403422T GR 3018303 T3 GR3018303 T3 GR 3018303T3
- Authority
- GR
- Greece
- Prior art keywords
- pct
- estradiol
- beta
- sec
- transdermal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITTO910907A IT1253265B (it) | 1991-11-25 | 1991-11-25 | Preparato a matrice copolimerica adesiva a base acrilica per il rilascio transdermico dell'estradiolo. |
PCT/EP1992/002704 WO1993010772A1 (en) | 1991-11-25 | 1992-11-24 | Transdermal estradiol delivery system |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3018303T3 true GR3018303T3 (en) | 1996-03-31 |
Family
ID=11409742
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR950403422T GR3018303T3 (en) | 1991-11-25 | 1995-12-05 | Transdermal estradiol delivery system. |
Country Status (12)
Country | Link |
---|---|
US (1) | US6156335A (el) |
EP (1) | EP0614356B1 (el) |
JP (1) | JPH07501335A (el) |
AT (1) | ATE128029T1 (el) |
AU (1) | AU666151B2 (el) |
CA (1) | CA2124209A1 (el) |
DE (1) | DE69205010T2 (el) |
DK (1) | DK0614356T3 (el) |
ES (1) | ES2078066T3 (el) |
GR (1) | GR3018303T3 (el) |
IT (1) | IT1253265B (el) |
WO (1) | WO1993010772A1 (el) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5554381A (en) * | 1993-08-09 | 1996-09-10 | Cygnus, Inc. | Low flux matrix system for delivering potent drugs transdermally |
DE4333595A1 (de) * | 1993-10-01 | 1995-04-06 | Labtec Gmbh | Transdermales therapeutisches System zur Applikation von Arzneimitteln auf die Haut |
GR1002079B (en) * | 1994-07-26 | 1995-12-05 | Lavipharm A E | System of a special structure and composition for the rapid transdermal administration of oestrogens. |
DE19526864A1 (de) * | 1995-07-22 | 1997-01-23 | Labtec Gmbh | Hormonpflaster |
DE19600347A1 (de) * | 1996-01-08 | 1997-07-10 | Lohmann Therapie Syst Lts | Hauthaftende pharmazeutische Zubereitung, insbesondere TTS zur Abgabe von 17-beta-Estradiol an den menschlichen Organismus |
US6623763B2 (en) | 1996-01-08 | 2003-09-23 | Lts Lohmann Therape-System Ag | Pharmaceutical preparation adhering to the skin, in particular a transdermal therapeutic system for the release of 17-β-estradiol to the human organism |
DE19830649C2 (de) * | 1998-07-09 | 2003-04-10 | Lohmann Therapie Syst Lts | Topisches Pflaster mit nichtsteroidalen Antirheumatika mit Säuregruppe |
GB0019745D0 (en) * | 2000-08-10 | 2000-09-27 | Univ Surrey | Gene expression element |
WO2002045701A2 (en) * | 2000-12-05 | 2002-06-13 | Noven Pharmaceuticals, Inc. | Crystallization inhibition of drugs in transdermal drug delivery systems |
DE10141652B4 (de) | 2001-08-24 | 2011-04-07 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung |
US6927267B1 (en) | 2002-03-07 | 2005-08-09 | Basf Ag | High solids dispersion for wide temperature, pressure sensitive adhesive applications |
DE10229733A1 (de) * | 2002-07-02 | 2004-01-22 | Basf Ag | Haftklebstoffe für Träger aus Weich-PVC |
AU2003254834B2 (en) | 2002-08-09 | 2009-02-19 | Fuso Pharmaceutical Industries, Ltd. | Female hormone-containing patch |
AU2005291098B2 (en) * | 2004-10-04 | 2011-11-24 | L'oreal | Cosmetic and/or dermatological composition for sensitive skins |
FR2889057B1 (fr) * | 2005-08-01 | 2008-07-18 | Oreal | Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches |
US7754256B2 (en) * | 2007-03-07 | 2010-07-13 | Stan Dennison | Nutritional composition |
US20080226698A1 (en) * | 2007-03-16 | 2008-09-18 | Mylan Technologies, Inc. | Amorphous drug transdermal systems, manufacturing methods, and stabilization |
FR2919501B1 (fr) * | 2007-08-02 | 2010-12-31 | Oreal | Utilisation d'hesperidine ou de l'un de ses derives pour la prevention et/ou le traitement des peaux relachees |
FR2920304B1 (fr) * | 2007-09-04 | 2010-06-25 | Oreal | Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse. |
BRPI0816214B8 (pt) * | 2007-09-04 | 2017-12-26 | Oreal | uso cosmético, composição cosmética e/ou dermatológica, e, métodos para o tratamento cosmético da pele, para o tratamento cosmético de sinais cutâneos de envelhecimento e/ou fotoenvelhecimento e para o tratamento cosmético para prevenir e/ou tratar substâncias queratinosas secas |
DE102008013701A1 (de) | 2008-03-11 | 2009-09-17 | Lts Lohmann Therapie-Systeme Ag | Transdermales Therapeutisches System mit stabilisierter Membran |
NZ589542A (en) * | 2008-05-30 | 2012-10-26 | Mylan Inc | Transdermal drug delivery system comprising an active agent in amorphous form and polyvinylpyrrolidone |
US8231906B2 (en) | 2008-07-10 | 2012-07-31 | Noven Pharmaceuticals, Inc. | Transdermal estrogen device and delivery |
KR20110082142A (ko) * | 2008-10-06 | 2011-07-18 | 밀란 테크놀로지즈 인코포레이티드 | 비정질 로티고틴 경피 시스템 |
DE102008059054A1 (de) | 2008-11-26 | 2010-05-27 | Otto Bock Pur Life Science Gmbh | Polyurethanpflaster für die transdermale Applikation von Wirkstoffen und Verfahren zu dessen Herstellung |
WO2011009800A1 (en) * | 2009-07-21 | 2011-01-27 | Basf Se | Film-to-film laminate, made by using an aqueous polymer dispersion as adhesive agent |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4906475A (en) * | 1988-02-16 | 1990-03-06 | Paco Pharmaceutical Services | Estradiol transdermal delivery system |
DE68917292T2 (de) * | 1988-02-26 | 1995-02-02 | Riker Laboratories Inc | Transdermales estradiol als therapeutisches sytem. |
US4994267A (en) * | 1988-03-04 | 1991-02-19 | Noven Pharmaceuticals, Inc. | Transdermal acrylic multipolymer drug delivery system |
EP0484543B1 (en) * | 1990-04-24 | 1995-12-13 | Teijin Limited | Plaster |
-
1991
- 1991-11-25 IT ITTO910907A patent/IT1253265B/it active IP Right Grant
-
1992
- 1992-11-24 JP JP5509788A patent/JPH07501335A/ja active Pending
- 1992-11-24 AU AU29451/92A patent/AU666151B2/en not_active Ceased
- 1992-11-24 AT AT92923782T patent/ATE128029T1/de not_active IP Right Cessation
- 1992-11-24 WO PCT/EP1992/002704 patent/WO1993010772A1/en active IP Right Grant
- 1992-11-24 DE DE69205010T patent/DE69205010T2/de not_active Expired - Lifetime
- 1992-11-24 US US08/244,132 patent/US6156335A/en not_active Expired - Fee Related
- 1992-11-24 ES ES92923782T patent/ES2078066T3/es not_active Expired - Lifetime
- 1992-11-24 DK DK92923782.4T patent/DK0614356T3/da active
- 1992-11-24 CA CA002124209A patent/CA2124209A1/en not_active Abandoned
- 1992-11-24 EP EP92923782A patent/EP0614356B1/en not_active Expired - Lifetime
-
1995
- 1995-12-05 GR GR950403422T patent/GR3018303T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0614356B1 (en) | 1995-09-20 |
DE69205010T2 (de) | 1996-02-22 |
US6156335A (en) | 2000-12-05 |
AU2945192A (en) | 1993-06-28 |
WO1993010772A1 (en) | 1993-06-10 |
DE69205010D1 (en) | 1995-10-26 |
ES2078066T3 (es) | 1995-12-01 |
ITTO910907A0 (it) | 1991-11-25 |
CA2124209A1 (en) | 1993-06-10 |
IT1253265B (it) | 1995-07-14 |
DK0614356T3 (da) | 1995-11-13 |
ATE128029T1 (de) | 1995-10-15 |
JPH07501335A (ja) | 1995-02-09 |
AU666151B2 (en) | 1996-02-01 |
ITTO910907A1 (it) | 1993-05-25 |
EP0614356A1 (en) | 1994-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3018303T3 (en) | Transdermal estradiol delivery system. | |
RU2176499C2 (ru) | Композиция для чрескожного введения стероидных лекарственных средств и содержащий ее препарат | |
DE10141652B4 (de) | Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen und seine Verwendung | |
MY106628A (en) | Estrogen-containing active substance plaster | |
US5725876A (en) | Compositions and methods for using low-swell clays in nicotine containing dermal compositions | |
CA2227538A1 (en) | Hormone patch | |
FI960556A0 (fi) | Transdermaalinen aktiivisten lääkeaineiden hitaan virtauksen antojärjestelmä | |
NZ524767A (en) | Composition for the transdermal delivery of fentanyl | |
US20040247656A1 (en) | Matrix controlled transdermal therapeutic system for the use of pramipexole and ropinirole | |
WO1997044018A9 (en) | Dermal compositions comprising acrylate polymers, nicotine and low-swell clay | |
US9700522B2 (en) | Transdermal patch and method for delivery of vitamin B12 | |
SK281623B6 (sk) | Náplasť obsahujúca účinnú látku na kontrolované podávanie estradiolu a jej použitie | |
Czech et al. | Acrylic pressure‐sensitive adhesive for transdermal drug delivery systems | |
NO953792L (no) | Plaster med virksomme stoffer for avgivelse av östradiol til huden | |
JP3361674B2 (ja) | 医療用粘着剤組成物 | |
CA2172738A1 (en) | Transdermal therapeutic system containing octyl dodecanol as crystallization inhibitor | |
KR20010084881A (ko) | 투명한 경피성 니코틴 전달 장치 | |
DE59402070D1 (de) | Nitroglycerinhaltiges pflaster, verfahren zu seiner herstellung und verwendung | |
JPH0543457A (ja) | 経皮吸収製剤 | |
KR950703948A (ko) | 피부를 통해 피소스티그민을 투여하기 위한 경피치료계, 및 이러한 계의 제조방법(transdermal therapeutic system for administering physostigmin through the skin〈 and a method of producing the system) | |
JP3192765B2 (ja) | テープ製剤 | |
JPH08104627A (ja) | 眠気よけ貼付剤 | |
KR20050046350A (ko) | 펜타닐을 유효성분으로 함유하는 경피투여제제 | |
KR960013236B1 (ko) | 에스트로겐/프로게스틴 경피 전달 장치 및 이를 포함하는 키트 | |
JPH0137375B2 (el) |